MedPath

Palonosetron versus ondansetron in preventing intrathecal morphine-induced postoperative nausea, vomiting, and pruritus in cesarean delivery: a double-blinded, randomized, placebo-controlled trial

Phase 4
Completed
Conditions
postoperative nausea, vomiting, and pruritus after intrathecal morphine use in cesarean delivery
postoperative
nausea
vomiting
pruritus
palonosetron
ondansetron
intrathecal opioid
intrathecal morphine
cesarean section
Registration Number
TCTR20210611005
Lead Sponsor
King Chulalongkorn Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
300
Inclusion Criteria

ASAII parturient aged 18 years or above scheduled for elective cesarean delivery under spinal anesthesia

Exclusion Criteria

1. Known allergy or contraindication to ondansetron, palonosetron, and other drugs in the study protocol
2. Having contraindication to or refusal of spinal anesthesia
3. Parturient with pregnancy-related complication such as fetal distress, severe pre-eclampsia
4. Parturient with preoperative symptoms of nausea and vomiting
5. Having coexisting skin disorder or pruritic skin disease
6. A patient who had received antiemetic, emetogenic, or steroid medication
7. The participant who needs an anesthetic technique conversion to general anesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
postoperative nausea, vomiting, pruritus PACU at 0, 30, 60, 90, 120 minutes after arrival and at the hospital ward at 6, 12, 24, 36, and 48 hours from the time of PACU arrival nausea and vomiting score (0 for no nausea or vomiting, 1 for mild nausea, 2 for severe nausea requiring rescue treatment, 3 for vomiting)
Secondary Outcome Measures
NameTimeMethod
postoperative pruritus PACU at 0, 30, 60, 90, 120 minutes after arrival and at the hospital ward at 6, 12, 24, 36, and 48 hours from the time of PACU arrival pruritus score (0 for no pruritus, 1 for mild pruritus, 2 for moderate pruritus requiring rescue treatment, 3 for severe pruritus)
© Copyright 2025. All Rights Reserved by MedPath